Therapy Watch delivers updated report from global lupus tracker

The latest report presents a view of the systemic lupus erythematosus (SLE) and lupus nephritis (LN) markets capturing the impact of new product launches. This multi-country study, conducted with rheumatologists and nephrologists, reports on patients with SLE and LN who were on B-cell depleters or immunosuppressants.

Lupus is a complex, chronic, and often invisible autoimmune disease that can severely impact quality of life. It is thought to affect at least five million people worldwide, with around 16,000 new cases each year in the US alone.

This patient record form tracker, helps our clients to understand the dynamics of the market, including initiation vs. maintenance therapy choice, drivers for prescribing, patient demographics, market shares, treatment patterns, and source of business.

Therapy Watch is a syndicated market tracking tool that provides marketing teams, brand managers and market researchers with real-world evidence into prescribing behaviors and market dynamics.